Skip to main content
. 2022 Mar 3;11(3):314. doi: 10.3390/pathogens11030314

Table 1.

Incidence/persistence/clearance of anal HPV infection among men who have sex with men.

HPV Genotypes Incident Infections Person Months Incidence/1000 Person Months (95% CI) Persistent Infections Person Months Persistence/1000 Person Months (95% CI) Cleared Infections Person Months Clearance/1000 Person Months (95% CI)
Any genotype a 77 2457 31.3 (24.7–39.2) 63 1314 47.9 (36.8–61.3) 161 1314 122.5 (104.3–143.0)
HR genotypes
Any HR genotype 42 2457 17.1 (12.3–23.1) 38 922 41.2 (29.2–56.6) 81 922 87.9 (69.8–109.2)
HPV 16 9 2187 4.1 (1.9–7.8) 8 271 29.5 (12.7–58.2) 14 271 51.7 (28.2–86.7)
HPV 18 5 2353 2.1 (0.7–5.0) 0 104 0.0 (0.0–35.5) 8 104 76.9 (33.2–151.6)
HPV 31 0 2434 0.0 (0.0–1.5) 0 23 0.0 (0.0–160.4) 2 23 87.0 (10.5–314.1)
HPV 33 3 2409 1.2 (0.3–3.6) 2 48 41.7 (5.0–150.5) 2 48 41.7 (5.0–150.5)
HPV 35 1 2409 0.4 (0.0–2.3) 1 48 20.8 (0.5–116.1) 3 48 62.5 (12.9–182.7)
HPV 39 3 2364 1.3 (0.3–3.7) 4 93 43.0 (11.7–110.1) 5 93 53.8 (17.5–125.5)
HPV 45 1 2380 0.4 (0.0–2.3) 1 77 13.0 (0.3–72.4) 5 77 64.9 (21.1–151.5)
HPV 51 4 2296 1.7 (0.5–4.5) 6 161 37.3 (13.7–81.1) 6 161 37.3 (13.7–81.1)
HPV 52 7 2223 3.1 (1.3–6.5) 4 234 17.1 (4.7–43.8) 14 234 59.8 (32.7–100.4)
HPV 56 1 2417 0.4 (0.0–2.3) 0 40 0.0 (0.0–92.2) 3 40 75.0 (15.5–219.2)
HPV 58 4 2271 1.8 (0.5–4.5) 8 186 43.0 (18.6–84.7) 8 186 43.0 (18.6–84.7)
HPV 59 2 2382 0.8 (0.1–3.0) 1 76 13.2 (0.3–73.3) 4 76 52.6 (14.3–134.8)
HPV 68 2 2339 0.9 (0.1–3.1) 3 118 25.4 (5.2–74.3) 7 118 59.3 (23.9–122.2)
LR genotypes
Any LR genotype 35 2457 14.2 (9.9–19.8) 25 902 27.7 (17.9–40.9) 80 902 88.7 (70.3–110.4)
HPV 6 2 2246 0.9 (0.1–3.2) 10 211 47.4 (22.7–87.2) 8 211 37.9 (16.4–74.7)
HPV 11 4 2239 1.8 (0.5–4.6) 4 218 18.3 (5.0–47.0) 12 218 55.0 (28.4–96.2)
HPV 26 1 2447 0.4 (0.0–2.3) 0 11 0.0 (0.0–335.4) 1 11 90.9 (2.3–506.5)
HPV 34 1 2443 0.4 (0.0–2.3) 0 14 0.0 (0.0–263.5) 1 14 71.4 (1.8–398.0)
HPV 40 3 2375 1.3 (0.3–3.7) 2 82 24.4 (3.0–88.1) 4 82 48.8 (13.3–124.9)
HPV 42 3 2339 1.3 (0.3–3.7) 3 118 25.4 (5.2–74.3) 9 118 76.3 (34.9–144.8)
HPV 43 2 2356 0.8 (0.1–3.1) 1 101 9.9 (0.3–55.2) 7 101 69.3 (27.9–142.8)
HPV 44 0 2457 0.0 (0.0–1.5) 0 0 NA 0 0 NA
HPV 53 3 2405 1.2 (0.3–3.6) 0 53 0.0 (0.0–69.6) 4 53 75.5 (20.6–193.2)
HPV 54 0 2446 0.0 (0.0–1.5) 0 11 0.0 (0.0–335.4) 1 11 90.9 (2.3–506.5)
HPV 55 1 2457 0.4 (0.0–2.3) 0 0 NA 0 0 NA
HPV 57 0 2457 0.0 (0.0–1.5) 0 0 NA 0 0 NA
HPV 61 3 2444 1.2 (0.3–3.6) 0 13 0.0 (0.0–283.8) 1 13 76.9 (1.9–428.6)
HPV 66 2 2424 0.8 (0.1–3.0) 0 34 0.0 (0.0–108.5) 3 34 88.2 (18.2–257.9)
HPV 67 2 2435 0.8 (0.1–3.0) 0 22 0.0 (0.0–167.7) 2 22 90.9 (11.0–328.4)
HPV 69 1 2428 0.4 (0.0–2.3) 1 29 34.5 (0.9–192.1) 1 29 34.5 (0.9–192.1)
HPV 70 0 2443 0.0 (0.0–1.5) 0 14 0.0 (0.0–263.5) 1 14 71.4 (1.8–398.0)
HPV 71 0 2443 0.0 (0.0–1.5) 0 14 0.0 (0.0–263.5) 1 14 71.4 (1.8–398.0)
HPV 72 0 2443 0.0 (0.0–1.5) 0 15 0.0 (0.0–245.9) 1 15 66.7 (1.7–371.4)
HPV 73 0 2421 0.0 (0.0–1.5) 1 36 27.8 (0.7–154.8) 3 36 83.3 (17.2–243.5)
HPV 81 3 2429 1.2 (0.3–3.6) 1 28 35.7 (0.9–199.0) 2 28 71.4 (8.7–258.0)
HPV 82 2 2348 0.9 (0.1–3.1) 2 110 18.2 (2.2–65.7) 6 110 54.5 (20.0–118.7)
HPV 83 0 2445 0.0 (0.0–1.5) 0 12 0.0 (0.0–307.4) 1 12 83.3 (2.1–464.3)
HPV 84 2 2318 0.9 (0.1–3.1) 0 139 0.0 (0.0–26.5) 11 139 79.1 (39.5–141.6)
Vaccine-preventable genotypes
9V genotypes b 35 2457 14.2 (9.9–19.8) 37 902 41.0 (28.9–56.5) 73 902 80.9 (63.4–101.8)
4V genotypes c 20 2457 8.1 (5.0–12.6) 22 687 32.0 (20.1–48.5) 42 687 61.1 (44.1–82.6)
2V genotypes d 14 2408 5.8 (3.2–9.8) 8 325 24.6 (10.6–48.5) 22 325 67.7 (42.4–102.5)
HPV 6/11 6 2457 2.4 (0.9–5.3) 14 429 32.6 (17.8–54.8) 20 429 46.6 (28.5–72.0)

Abbreviations: HPV, human papillomavirus; CI, confidence interval; HR, high-risk; LR, low-risk; NA, not available; a ≥1 of the 37 genotypes were detected; b 9V genotypes include HPV 6, 11, 16, 18, 31, 33, 45, 52, and 58; c 4V genotypes include HPV 6, 11, 16, and 18; d 2V genotypes include HPV 16 and 18.